Sartorius

Gottingen, Germany Founded: 1870 • Age: 156 yrs Listed
Laboratory and biopharmaceutical equipment is developed for production processes.

About Sartorius

Sartorius is a publicly listed company based in Gottingen (Germany) founded in 1870 by Florence Kurth. Laboratory and biopharmaceutical equipment is developed for production processes. The company has 13,530 employees. Sartorius has completed 19 acquisitions, including ALS Automated Lab Solutions, Albumedix and AllPure Technologies. Its chief executive, as recorded, is Joachim Kreuzburg. Its website sartorius.com draws about 354 thousand monthly visits. Its Indian entity Sartorius Stedim India Private Limited reported revenue of ₹1,025 Cr. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Diversified.

Company details

Sartorius was founded in 1870 in Gottingen, Germany, and operates in the biopharmaceutical and laboratory equipment sector. A broad portfolio is offered, covering filtration, fermentation, cell cultivation, and fluid management in biopharmaceutical production. High-tech laboratory equipment, consumables, and advanced bioprocess technology are provided, along with industrial scales. Service, calibration, and verification support are also available to clients globally.

  • Headquarters Gottingen, Germany
  • Employees 13,530
  • Founders Florence Kurth
  • Stage Public
  • Sectors
    Healthcare
  • Website category Science and Education · Chemistry
  • Website sartorius.com/en
  • Social LinkedIn X Facebook YouTube
  • Legal Name Sartorius Ag
Key Metrics
  • Indian entity revenue
    ₹1,025 Cr

    FY 2025 · +17% YoY

  • Indian entity net profit
    ₹19.16 Cr

    FY 2025 · 2% margin

  • Indian entity EBITDA
    ₹48.81 Cr

    FY 2025 · 5% margin

  • Investors
  • Employee Count
    13,530
  • Investments & Acquisitions

Apps and channels of Sartorius

its YouTube channel Sartorius has 10.6K subscribers and 30 videos.

Sartorius
YouTube 10.6K subscribers 30 videos Science & Technology
Open channel

Videos from Sartorius

The most watched videos on Sartorius's YouTube channel, Sartorius (10.6K subscribers). Click a video to play it here.

Insights into Extracellular Vesicle Labeling
16.6K views
People at Sartorius
420 views
Octet® R8e Biolayer Interferometry (BLI) System | Outstanding Sensitivity. Reliable Data
384 views
CellCelector Tutorial: Simple Picking Protocol
369 views

More on Sartorius.

Funding Insights of Sartorius

  • Total Rounds 7
  • Investors Count 1

All 7 funding rounds of Sartorius with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2018Grant––
Nov 2017$301,271Grant––
–
Feb 2017Grant––
Jan 2017$274,497Grant––
Jun 2015Grant––
May 2015$58,469Grant––
Jan 2014Grant––
Valuation history

1 investors in total: 1 institutional.

Investors in Sartorius

Sartorius has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Premium access

Investor details for Sartorius

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Sartorius Stedim India Private Limited (Sartorius)

Sartorius Stedim India Private Limited is the primary company behind Sartorius. The board of Sartorius Stedim India Private Limited currently have 3 directors; the longest-serving is Anthony Joseph Prakash, appointed in 2017. 12 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Anthony Joseph Prakash
DIN 07710751
Managing Director01 Feb 20179 yrs 9 moSartorius Stedim India Private Limited
William Peer Brauer
DIN 09719330
Director16 Sep 20224 yrs 1 moSartorius Stedim India Private Limited
Francois Ernest Himmelspach
DIN 10658832
Director12 Jun 20242 yrs 4 moSartorius Stedim India Private Limited

People of Sartorius

88 people are tracked at Sartorius (28 in leadership, 13 in board & advisors, 47 in team); the tracked headcount is 13,530.

NameRoleGroup
Florence Kurth
FounderLeadership
Joachim Kreuzburg
CEOLeadership
René Fáber
Head, Bioprocess Solutions DivisionLeadership
Sebastian Handt
Head Of PDLeadership
Stephen Piela
Head Of Product Management - Cryo Solutions & Final FillLeadership
Ian Ransome
Head Of Product Management, Ambr Systems, At SartoriusLeadership
Mario Becker
Global Head Of Product Group Bioreactor TechnologiesLeadership
Doug Broughman
Director Of OperationsLeadership
Eric Kummer
Head Of Operations BPSLeadership
Markus Frey
Head Of Product Development Bioreactor TechnologiesLeadership
Sebastian Lux
Head Of Product Development, BPS Digital SolutionsLeadership
Thorsten Adams
Head Of Product Management And Development Fluid ManagementLeadership
Claire Michiels
Head Of Consumables Technologies Quality And Regulatory ComplianceLeadership
Lars Hanf
Head Of Marketing, SVPLeadership
Christine V.
Marketing Senior Business Partner FMTLeadership
Frédéric Bazin
Head Of Product Development Group - Bag & ConnectLeadership
Maurice Phelan
President Sartorius Stedim North AmericaLeadership
Florian Funck
CFOLeadership
Elise Treuvey
Head Of Quality Management System Division BPSLeadership
Jan Krieger
Head Of Global Freight & Distribution ManagementLeadership

68 more people are available in the full profile.

Premium access

Complete people profiles for Sartorius

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Sartorius

Sartorius is a publicly listed company on the EURONEXT with ticker symbol DIM in France, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date06 Apr 1999
  • Listed onFRA: SRT
  • Listed entitySartorius Stedim Biotech SA
  • Exchange sectorHealth technology
  • ISINDE0007165607
  • Share price203.00 EUR (+0.74% on the day) · 2026-10-14
  • Market capitalisation15,644,599,531.00 EUR
  • Price to earnings71.5
  • EPS (diluted, trailing year)2.84 EUR
  • Dividend yield0.36%

Financials of Sartorius

Figures of Sartorius Stedim India Private Limited, the primary company behind Sartorius, for FY 2025. Revenue was ₹1,025 Cr (+17% year on year). Net profit was ₹19.16 Cr (2% margin). EBITDA was ₹48.81 Cr (5% margin). Revenue has grown at a compounded annual rate of +12% over three years and +24% over five years.

  • ₹1,025 CrRevenue · FY 2025 · +17% YoY
  • ₹19.16 CrNet profit · 2% margin
  • ₹48.81 CrEBITDA · 5% margin
  • ₹96 LakhPaid-up capital
  • 574Employees (provident fund records)
  • +12%Revenue CAGR, 3 years
  • +24%Revenue CAGR, 5 years
Exchange-reported annual figures
YearRevenueNet incomeEBITDA
20253.54B EUR154.9M EUR1.07B EUR
20243.38B EUR84.0M EUR994.7M EUR
20233.40B EUR205.6M EUR1.00B EUR
20224.17B EUR678.1M EUR1.48B EUR
20213.45B EUR318.9M EUR1.19B EUR

Balance sheet, profit and loss, cash flow and ratios of Sartorius Stedim India Private Limited are on its company page.

Premium access

Detailed financial statements for Sartorius

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Sartorius

Sartorius has strategically engaged in corporate development activities, having acquired 19 companies. Notable acquisitions include ALS Automated Lab Solutions, Albumedix and AllPure Technologies.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Optical clearing agents for tissue transparency are developed by Visikol.
visikol.comNew Brunswick, United States2012Apr 2025••••
Focused on development, optimization, and commercialization of in vitro models and methods.
mattek.comAshland, United States1985Apr 2025••••
Transfection Solutions for Healthcare and Life Sciences organizations
polyplus-transfection.comIllkirch Graffenstaden, France2001Mar 2023$2.61B
Albumin-based products and technologies for biotherapeutics development are provided.
albumedix.comLyngby, Denmark2016Aug 2022$502M
Provider of single cell and colony isolation system
als-jena.comJena, Germany1998Dec 2021••••
Specialized media and feeds for cell culture are provided.
xell.agBielefeld, Germany2009Jul 2021••••
Supplier of high-quality reagents and tools for cell therapy and regenerative medicine.
cellgenix.com1994Jul 2021••••
Crossflow hollow fiber products are manufactured for filtration applications.
watersep.netMarlborough, United States2007Dec 2020••••
Monolithic chromatographic columns are developed using Convective Interaction Media technology.
biaseparations.comVillach, Austria1998Oct 2020$423M
Cell culture media development and manufacturing services
bioind.comCromwell, United States1982Dec 2019$49.86M
Premium access

Complete acquisition details for Sartorius

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Sartorius

14 dated milestones of Sartorius across 155 years, from founding to its latest funding, stage changes and deals.

  1. Founded Sartorius is founded.
  2. IPO Lists on the stock exchange (IPO).
  3. Funding First funding round.
  4. Funding Latest funding round, Grant,.
  5. Acquisition Acquires Biological Industries.
  6. Acquisition Acquires BIA Separations.
  7. Acquisition Acquires Watersep.
  8. Acquisition Acquires CellGenix.
  9. Acquisition Acquires Xell.
  10. Acquisition Acquires ALS Automated Lab Solutions.
  11. Acquisition Acquires Albumedix.
  12. Acquisition Acquires Polyplus Transfection.
  13. Acquisition Acquires Visikol®.
  14. Acquisition Acquires MatTek.

Web traffic of Sartorius

The website of Sartorius (sartorius.com) receives about 354.4K visits a month and ranks #138,906 among all websites worldwide, #8,951 in Chemistry.

  • Monthly visits
    354.4K

    ▲ 6.8% vs previous month

  • Unique visitors
    148.2K

    per month

  • Global rank
    #138,906

    among all websites

  • Category rank
    #8,951

    Science and Education · Chemistry

Similar websites

Websites whose visitors overlap most with Sartorius. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
sartorius.balances.com
sartorius.balances.com
100%
–
ohaus.com
99%
#275,997View details
denverinstrument.com
93%
View details
perkinelmer.de
perkinelmer.de
82%
–
hidenanalytical.com
82%
18.4K#1,457,595View details
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 40 similar websites and full traffic analytics for Sartorius

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Sartorius

Premium access

Complete news archive for Sartorius

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sartorius

Sartorius was founded in 1870 and raised its 1st funding round 144 years after it was founded.

Sartorius is headquartered in Gottingen, Germany. It is registered at Gottingen, Niedersachsen, Germany.

Joachim Kreuzburg is the CEO of Sartorius, as recorded in our data.

Sartorius has 13,530 employees.

The primary company behind Sartorius, Sartorius Stedim India Private Limited, reported revenue of ₹1,025 Cr for FY 2025, up 17% year on year.

Sartorius was founded in 1870 in Gottingen, Germany, and operates in the biopharmaceutical and laboratory equipment sector. A broad portfolio is offered, covering filtration, fermentation, cell cultivation, and fluid management in biopharmaceutical production. High-tech laboratory equipment, consumables, and advanced bioprocess technology are provided, along with industrial scales. Service, calibration, and verification support are also available to clients globally.

Yes, Sartorius is publicly traded on EURONEXT under the ticker symbol DIM.

Sartorius has made 19 acquisitions, including ALS Automated Lab Solutions, Albumedix, and AllPure Technologies.

Sartorius has 1 investor. Key investors include European Union.

Sartorius operates through Sartorius Stedim India Private Limited.

The legal entities of Sartorius currently have 3 directors, including Anthony Joseph Prakash, Francois Ernest Himmelspach, William Peer Brauer.

The website of Sartorius receives about 354 thousand visits a month and ranks #138,906 among all websites worldwide.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available